showed a trendp = 0.069
Among patients analyzed prior to any therapy, the g.3A>C U1 mutation showed a trend for enrichment in patients diagnosed with CLL compared to monoclonal B-cell lymphocytosis (MBL) (26/850 (3.1%) vs 1/173 (0.6%), p = 0.069).
Among patients analyzed prior to any therapy, the g.3A>C U1 mutation showed a trend for enrichment in patients diagnosed with CLL compared to monoclonal B-cell lymphocytosis (MBL) (26/850 (3.1%) vs 1/173 (0.6%), p = 0.069).